Merck & Co. ١١ مايو ٢٠٢٦ Merck makes a new move in Astra battle | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Merck & Co. ١١ مايو ٢٠٢٦ Amid M&A buzz, Inhibrx's OX40-Keytruda combo shows promise in early look at midphase data - Fierce Biotech
PLoS Biology ١١ مايو ٢٠٢٦ The problem with one-size-fits-all medicine: Biological sex and the aging immune system
PLoS Biology ١١ مايو ٢٠٢٦ USP39 promotes antiviral defense through post-transcriptional control of RIG-I and stabilization of STING
BioPharma Dive ١١ مايو ٢٠٢٦ Inhibrx delivers ‘differentiated’ cancer drug data; Fractyl starts diabetes gene therapy trial
Charles River ١١ مايو ٢٠٢٦ Charles River Laboratories Introduces AI-Powered, End-to-End Workflow - Contract Pharma
Endpoints News ١١ مايو ٢٠٢٦ Braveheart Bio's Hengrui-licensed cardiac drug scores second clinical win
FierceBiotech ١١ مايو ٢٠٢٦ Novo salvages happy ending for scrapped Parkinson’s cell therapy via deal with AI biotech
GE HealthCare ١١ مايو ٢٠٢٦ GE HealthCare next-gen SIGNA MR technology helps advance research discovery and translate innovation into clinical impact - Business Wire